Christopher R. Noyes


Noyes, Christopher R.

Christopher Noyes advises pharmaceutical and biotechnology companies on complex intellectual property matters. He has successfully litigated life sciences cases in district courts across the United States, including taking numerous cases to trial in popular venues for Hatch-Waxman litigation, such as the District of New Jersey and District of Delaware.

With more than 14 years of experience, he has helped his clients to protect their intellectual property and defend their business around the globe. During his career, Mr. Noyes has litigated cases involving small molecules, biologics, vaccines, pharmaceutical formulations, DNA diagnostic technology and more. He also has experience litigating intellectual property disputes for a variety of high technology clients, including those in the semiconductor and solar industries.

Honors & Awards

  • Recommended in the 2016 edition of The Legal 500 United States for intellectual property: patent litigation: full coverage
  • Named a "New York Metro Super Lawyer" in the 2013-2017 editions of Metro Edition magazine 
  • Named a "New England Super Lawyer" in the 2013 and 2014 issues of Boston Magazine and named a "Rising Star" for intellectual property litigation in the 2012 and 2014 issues of Boston Magazine

Publications & News


June 9, 2017

The Legal 500 United States 2017 Recognizes 125 WilmerHale Lawyers Across 28 Practice Areas

The Legal 500 United States has released its 2017 rankings, recommending 125 WilmerHale lawyers—including 12 who are named to its elite “Leading Lawyers” list and two on its “Next Generation Lawyers” list—and 28 practice areas in its 11th edition.

May 9, 2017

WilmerHale Earns Win for Braintree Labs in Hatch-Waxman Case

Braintree Laboratories, Inc. was victorious at the Federal Circuit when the appeals court reversed a district court's grant of summary judgment of noninfringement for Breckenridge Pharmaceutical and remanded with instructions to enter judgment in Braintree's favor.

May 5, 2017

Fed. Circ. Undoes Breckenridge Generic Laxative Patent Win

Law360 explores the Federal Circuit's ruling that Breckenridge Pharmaceutical Inc.'s planned generic version of the laxative drug Suprep infringes a patent owned by WilmerHale client Braintree Laboratories Inc., reversing a New York federal judge's 2016 ruling.

June 22, 2016

The Legal 500 United States 2016 Recognizes 111 WilmerHale Lawyers Across 30 Practice Areas

The guide's rankings are based on a series of criteria, including client feedback, interviews with private practice lawyers, and its own research.

August 3, 2015

Protecting the Brick: LEGO's Global IP Enforcement Efforts

An article by Christopher Noyes and Crystal Roberts published in the August 3, 2015 issue of the New York Law Journal.

June 12, 2015

Braintree Labs Defeats Novel Labs in Ongoing Patent Infringement Case

On June 2, 2015, WilmerHale obtained a significant victory for Braintree Laboratories, Inc. (Braintree) in a patent infringement matter at the US District Court for the District of New Jersey.

April 13, 2015

Nature-Based Claims And the Patent-Eligibility Landscape

An article by Robert Gunther, Christopher Noyes and Omar Khan published in the April 13, 2015 issue of the New York Law Journal.

October 13, 2014

WilmerHale Named Best Patent Litigation Firm by The Legal 500 US

WilmerHale has been named the nation's best law firm in the category of IP: Patent Litigation by The Legal 500 United States as part of its inaugural awards program.

September 12, 2014

When Inter Partes Review Meets Hatch-Waxman Patents

An article by Christopher Noyes, Emily Whelan, Corinne Atton and Heather Petruzzi, published by Law360 as part of a series of articles authored by the firm on the topic of post-grant proceedings.

June 19, 2013

Braintree Labs Wins Patent Infringement Case Against Novel

On June 19, WilmerHale obtained a favorable final judgment in the US District Court for the District of New Jersey for Braintree Laboratories, Inc. (Braintree) in its patent infringement case against Novel Laboratories (Novel).

Recent Highlights

  • Secured a significant victory at the Federal Circuit for Braintree Laboratories, Inc. when the appeals court reversed a district court's grant of summary judgment of noninfringement for Breckenridge Pharmaceutical and remanded with instructions to enter judgment in Braintree's favor. This Hatch-Waxman matter involved a patent owned by Braintree pertaining to its product SUPREP, a highly successful product designed to cleanse the colon safely before a colonoscopy.
  • Achieved a significant victory on behalf of our clients, multiple medical device and diagnostics companies, when the District of Delaware granted summary judgment invalidating the key patent asserted against our clients. The judge ultimately entered a final judgment as to that patent, stayed the remainder of the claims and closed the cases.
  • Obtained a favorable result for our client, a large pharmaceutical company, resolving global litigation with a rival pharmaceutical company related to their competing vaccines. A settlement resolved proceedings in Australia, Ireland, Italy, the United Kingdom, the United States, the European Patent Office and the USPTO. Mr. Noyes was the lead New York partner for the litigation.
  • Acted as second chair and conducted all cross examinations of the defense experts in a remand trial on infringement and obtained a victory for the client when the judge found that the proposed generic product would infringe five asserted claims of our client's patent if marketed and sold. Representation began in 2013 with trial where Mr. Noyes was second chair and was primarily responsible for presenting the case on validity. The Court found that the claims of the patent at issue are invalid for obviousness, anticipation or indefiniteness.

Professional Activities

Mr. Noyes has served as a faculty member for the Massachusetts Continuing Legal Education Pretrial Litigation Basics Seminar and as an advisor to students participating in the Harvard Law School mock trial program.

Mr. Noyes is a member of the American Bar Association and the New York State Bar Association.


Skip Navigation Links.


JD, cum laude, University of Michigan Law School, 2002, Order of the Coif; Article Editor, Michigan Journal of Race and Law

BA, Political Science, summa cum laude, University of Vermont, 1999, Phi Sigma Alpha

Bar Admissions

New York



Senator Patrick Leahy, Ranking Member, Senate Judiciary Committee

The Hon. Marilyn S. Skoglund, Vermont Supreme Court, 2002 - 2003

Skip Navigation Links.